Bio-Techne Corp
(STU:TE1)
€
69.5
0 (0%)
Market Cap: 11.07 Bil
Enterprise Value: 11.27 Bil
PE Ratio: 80.74
PB Ratio: 5.63
GF Score: 95/100 Bio-Techne Corp at Evercore ISI HealthCONx Conference Transcript
Nov 29, 2023 / 07:10PM GMT
Release Date Price:
€57.5
(+2.68%)
Vijay Muniyappa Kumar
Evercore ISI Institutional Equities, Research Division - Senior MD and Head of Medical Supplies & Devices and Life Science Tools & Diagnostics Team
Thanks, everyone, for joining us this afternoon. I'm Vijay Kumar, the life science tools diagnostics and metric analyst. Pleasure to have with us Bio-Techne, representing the company, we have CEO, Chuck Kummeth. And I guess, the incoming as well. Kim Kelderman. Gentleman, thank you for spending the time with us.
Questions & Answers
Vijay Muniyappa Kumar
Evercore ISI Institutional Equities, Research Division - Senior MD and Head of Medical Supplies & Devices and Life Science Tools & Diagnostics Team
So before we get started, this tool has been pretty noisy this year. And one would have thought a business like Techne with reagent exposure to be relatively protected. Obviously, you've had your own sort of macro issues to face with. Any opening comments you want to make out on how third quarter progressed for Bio-Techne and how the macro environment played out?
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot